This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a National Science Advisory Board for Biosecurity (NSABB) meeting.
Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding federal oversight of dual-use research, defined as biological research with legitimate scientific purposes that could be misused to pose a biological threat to public health and/or national security.
The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend Start Printed Page 12209should register online at http://www.biosecurityboard.gov/meetings.asp or by calling The Hill Group (Contact: Jenny Chun) at 301-897-2789, ext. 115. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration.
Name of Committee: National Science Advisory Board for Biosecurity.
Date: March 30, 2006.
Time: 8 a.m. to 6:15 p.m.
Agenda: Presentations and discussions regarding: (1) Criteria for identifying dual use research; (2) a code of conduct for the life sciences; (3) principles and tools for the responsible communication of dual use research; (4) international perspectives on dual use research; (5) synthetic genomics; (6) public comments; and (7) other business of the Board.
Place: The National Institutes of Health, Building 31, 6C-Room 10, Bethesda, Maryland.
Contact Person: Allison Chamberlain, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, MD 20892, (301) 402-3090.
This meeting will also be Webcast. The draft meeting agenda and other information about NSABB, including information about access to the Webcast and pre-registration, will be available at http://www.biosecurityboard.gov/meetings.asp.
Any member of the public interested in presenting oral comments at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by March 17, 2005 and should be sent via email to email@example.com with “NSABB Public Comment” as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Allison Chamberlain. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person.Start Signature
Dated: March 1, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-2215 Filed 3-8-06; 8:45 am]
BILLING CODE 4140-01-M